CONSENSUS OF VIETNAM PEDIATRIC ASSOCIATION DENGUE HEMORRHAGIC FEVER BURDEN AND PREVENTION RECOMMENDATIONS FOR CHILDREN IN VIETNAM
##plugins.themes.vojs.article.main##
Tóm tắt
Dengue hemorrhagic fever (DHF) is an infectious disease caused by the dengue virus. There are 4 serotypes of the dengue virus: DENV-1, DENV-2, DENV-3 and DENV-4. The virus is transmitted from infected people to healthy people by mosquito bites. The Aedes aegypti mosquito is the main vector. In Vietnam, Dengue hemorrhagic fever is a year-round epidemic in many provinces and localities, causing a burden of disease and economic pressure on individuals, families and the health-social system.
Although Vietnam is doing very well in controlling the DHF epidemic with a prevention system and treatment regimen that has been regularly updated in each stage. However, it still requires sustainable prevention measures, which is also a challenge and urgent requirement today.
Based on this urgent need, the Vietnam Pediatric Association organized an expert workshop on the topic “Burden of Dengue Fever and Prevention Recommendations for Children in Vietnam” with the participation of Professors, Doctors, and Physicians who are leading experts in many fields such as Pediatrics, Infectious Diseases, Preventive Medicine. Through this workshop, the Vietnam Pediatric Association has developed a “Consensus: Burden of Dengue Fever and Prevention Recommendations for Children in Vietnam”.
The consensus content includes information in the reports of the reporters, reference documents, current policies, especially in-depth discussions by experts on the current situation of Dengue hemorrhagic fever in Vietnamese children. The consensus summarizes the epidemiological, clinical characteristics and current burden of Dengue hemorrhagic fever and updates effective preventive measures to help medical staff in the pediatric system to refer to and provide appropriate advice to people to effectively prevent Dengue hemorrhagic fever. The Vietnam Pediatric Association would like to express our sincere thanks to the experts, editorial board, and conference organizers who participated in and contributed to this consensus.
##plugins.themes.vojs.article.details##
Tài liệu tham khảo
2. WHO. Global Dengue Surveillance. Last accessed on 24 Sep, 2024. DOI: Global dengue surveillance (shiny(apps.io)
3. WHO. WHO position paper on Dengue vaccines. May, 2024. DOI: WHO position paper on dengue vaccines, May 2024
4. Biswal S et al. Lancet 2020;395:1423–1433
5. Rivera L et al. Clin Infect Dis 2022;75:107–117
6. Vietnam Ministry of Health (2023). Guidelines for diagnosis and treatment of Dengue hemorrhagic fever. Decision No.2760/QD-BYT
7. Vietnam Ministry of Health (2014). Guidelines for surveillance and prevention of Dengue hemorrhagic fever. Decision No.3711/QD-BYT.
8. National Institute of Hygiene and Epidemiology (2022). Surveillance and prevention of some common human diseases by insects and medical animals.Medical Publishing House. Ha Noi.
9. Qdenga prescription information is licensed by the Ministry of Health on May 14, 2024. DOI:https://dichvucong.dav.gov.vn/congbothuoc